Table 3.
Control | Depressed | ANCOVA* | |||||
---|---|---|---|---|---|---|---|
|
|
|
|||||
Cytokine | n | Mean (95% CI) | n | Mean (95% CI) | Statistic | p value† | Adjusted p value‡ |
IL1-β | 30 | 1.09 (0.78–1.52) | 39 | 0.94 (0.72–1.24) | t62 = 0.68 | 0.50 | 0.55 |
IL2 | 30 | 0.66 (0.34–1.29) | 39 | 0.27 (0.16–0.47) | t61 = 2.15 | 0.036 | 0.07 |
IL4 | 30 | 1.02 (0.74–1.41) | 38 | 0.85 (0.65–1.11) | t62 = 0.93 | 0.36 | 0.43 |
IL5 | 30 | 0.90 (0.65–1.25) | 39 | 1.25 (0.96–1.62) | t48 = −1.64 | 0.11 | 0.15 |
IL6 | 30 | 1.11 (0.72–1.69) | 39 | 0.72 (0.51–1.02) | t62 = 1.63 | 0.11 | 0.15 |
IL13 | 24 | 0.92 (0.7–1.2) | 31 | 0.64 (0.51–0.79) | t62 = 2.23 | 0.029 | 0.06 |
IL33 | 25 | 1.00 (0.74–1.36) | 31 | 0.52 (0.41–0.67) | t49 = 3.57 | 0.001 | 0.009 |
IFN-γ | 30 | 0.96 (0.66–1.39) | 39 | 0.50 (0.37–0.68) | t62 = 2.85 | 0.006 | 0.022 |
TNF-α | 30 | 1.04 (0.79–1.38) | 39 | 0.64 (0.51–0.8) | t62 = 2.86 | 0.006 | 0.022 |
CCL2 | 30 | 1.29 (0.89–1.68) | 39 | 0.76 (0.56–1.02) | t62 = 2.37 | 0.021 | 0.06 |
COX2 | 25 | 0.80 (0.56–1.13) | 31 | 0.89 (0.67–1.17) | t49 = −0.51 | 0.61 | 0.61 |
ANCOVA = analysis of covariance; CCL2 = chemokine ligand 2; CI = confidence interval; COX2 = cyclooxygenase-2; IFN = interferon; IL = interleukin; TNF = tumour necrosis factor; VLPFC = ventrolateral prefrontal cortex.
Adjusted means were estimated by ANCOVA on log-transformed KP metabolites to test control v. depressed differences, adjusting for age, sex and postmortem interval.
Significant levels for unadjusted values for multiple comparisons.
Significant levels for adjusted values for multiple comparisons using the Benjamini–Hochberg modification of the Bonferroni method.